Neurocrine Biosciences Inc. (NBIX) declined -13.44% or -13.37 to $86.13. It is approximately 3.24 million shares traded, which is 390.88% compare to the average total volume 827725. The market cap of NBIX is $7.81 billion. The year to date change is 12.04%. The 52 week price range is from $67.33 to $126.98. Price of NBIX have changed -8.29% during last week. It have changed -8.82% over last month, -16.64% over last 3 months, 14.78% over last 6 months and 31.93% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 113.82. It is 32.15% above current price. The 200-day Moving Averages for NBIX is 99.47. It is 15.49% above current price. The 52-week High is 126.98. It is 47.43% from the current price. The 52-week Low is 67.33. It is -21.83% from current price.
There are some statistics of NBIX. It is has market cap $7.81 billion. The share outstanding is 90.68 million. The average volume is 827725. The revenue is 94.52M. The gross profit is 93.76M. The percent of top 15 Institution holding is 75.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is 2.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is 1.17%.